IL18 and atherosclerosis: Because SMC proliferation, migration and proinflammatory phenotype switching contribute to atherosclerosis development and progression, we hypothesized that EF24 could exert anti-atherosclerosis effects by inhibiting IL-18-induced ASMC proliferation, migration and proinflammatory phenotype switching, and determined the underlying molecular mechanisms.